← CJC-1295 overview

CJC-1295 Dosage & Reconstitution Guide

Research and educational use only — not medical advice, and not for human consumption. The figures below are summarized from public sources, product labeling, and community reports, and are not a prescription or a substitute for a qualified clinician.

Typical dose
1-2 mg
Route
Subcutaneous injection
Frequency
1–3 injections daily
After mixing
5 mg/mL (5000 mcg/mL)

Reconstitution

CJC-1295 ships as a freeze-dried (lyophilized) powder that has to be mixed with bacteriostatic water before use. Draw 2 mL of bacteriostatic water into a syringe and add it to a 10 mg vial, letting the stream run down the inside wall of the glass rather than blasting the powder directly. Swirl gently — never shake — until the solution is clear, then keep it refrigerated.

Worked example. 2 mL into a 10 mg vial gives a concentration of 5 mg/mL (5000 mcg/mL). A 100 mcg dose then works out to 0.02 mL = 2 units on a U-100 insulin syringe. Scale the water volume up or down to make your target dose land on an easy-to-read mark (1 unit = 0.01 mL).

  1. Wipe both vial stoppers (peptide and bacteriostatic water) with an alcohol swab and let them dry.
  2. Draw 2 mL of bacteriostatic water into a syringe.
  3. Inject it slowly against the inside wall of the peptide vial.
  4. Swirl gently until fully dissolved; do not shake.
  5. Label the vial with the contents, concentration, and date, and store it in the refrigerator.

Dosing schedule

Phase Dose Volume Insulin units (U-100) Notes
Weeks 1–2 100 mcg 0.02 mL 2 units 1–2× daily, paired 1:1 with a GHRP
Weeks 3+ 100 mcg 0.02 mL 2 units 1–3× daily — ~100 mcg is the saturation dose
Upper range 200 mcg 0.04 mL 4 units per dose; going higher adds little

Timing & cycling

Short half-life (~30 min), so it is dosed DAILY — and almost always injected together with a GHRP (Ipamorelin, GHRP-2/6) in the same syringe. Fasted, 30 minutes before food; bedtime and post-workout are the high-value slots.

Cycle length. 8–12 weeks, then reassess with 4 weeks off.

Storage & handling

Keep the lyophilized (unmixed) vial refrigerated at 2–8 °C (36–46 °F) in a dry, dark place — it tolerates short periods at room temperature during shipping. Once reconstituted, store it at 2–8 °C, never frozen, and use it within about 2–4 weeks (sooner if the solution turns cloudy or discolored). Swab the stopper before every draw and use a fresh needle each time.

Supplies you'll need

  • CJC-1295 vials — about 3 for an 8-week run at the upper dose
  • Bacteriostatic water — 2 mL per vial (a 10–30 mL multi-dose bottle covers several vials)
  • U-100 insulin syringes (0.3–0.5 mL / 30–50 unit barrels are easiest to read) — roughly 112 for 8 weeks, plus spares
  • Alcohol swabs — one per injection and one per vial draw
  • Sharps container for safe needle disposal

Key points

  • This is the SHORT-ACTING version (a.k.a. Mod GRF 1-29 / "CJC-1295 no-DAC") — it must be dosed DAILY. Only CJC-1295 WITH DAC (separate page) is the once-weekly 1–2 mg protocol; do not run this one weekly.
  • ~100 mcg is the community "saturation" dose — the pituitary can't use much more per pulse, so 100 mcg 1–3× daily beats one big shot.
  • The published synergy is in the 1:1 pairing with a GHRP (e.g. 100 mcg + 100 mcg in one syringe), fasted, with a 15–20 minute wait before eating.

What to monitor

IGF-1 at 6–8 weeks; fasting glucose on long runs.

Legal & prescription status

No legal prescription exists. It is an unapproved research chemical, sold only for laboratory research and labelled 'not for human consumption.' It is not FDA-approved for any human use.

References

  1. doi.org
  2. doi.org
  3. doi.org
  4. doi.org
  5. doi.org

This guide is for research and educational purposes only. It is not medical advice and does not describe a product approved for human use. Always consult a qualified healthcare professional before considering any peptide protocol.